33 studies found for:    Open Studies | "Platelet Aggregation Inhibitors"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Platelet Aggregation Inhibitors"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Plavix, Prasugrel and Drug Eluting Stents Pilot Trial
Conditions: Coronary Artery Disease;   Platelet Aggregation Inhibitors;   PCI- Percutaneous Coronary Intervention
Interventions: Drug: Loading Dose Arm;   Drug: Maintenance Dose Arm
2 Unknown  Cost-effectiveness of Genotype Guided Treatment With Antiplatelet Drugs in STEMI Patients: Optimization of Treatment
Conditions: Myocardial Infarction;   STEMI
Intervention: Genetic: CYP2C19 genotyping
3 Recruiting Research of Resistance to Antiplatelet Agents and Development of Tailored Treatment Model for Patients With Coronary Artery Disease
Conditions: Cardiovascular Diseases;   Coronary Artery Disease
Intervention:
4 Not yet recruiting Pharmacokinetics of Antiplatelet Drugs in Diabetic pAtients
Condition: Diabetes
Intervention: Drug: Clopidogrel, Prasugrel, Ticagrelor
5 Unknown  Evaluation of Antiplatelet Drug Resistance in Taiwanese With VASP & Platelet Mapping ™ Assay
Condition: 30 Healthy People
Intervention: Drug: Clopidogrel and proton pump inhibitors
6 Recruiting Ticagrelor and Endothelial Function
Condition: Antiplatelet Agents; Endothelial Function; Pleotropic Effects
Interventions: Drug: ticagrelor;   Drug: prasugrel
7 Recruiting Apixaban Versus Antiplatelet Drugs or no Antithrombotic Drugs After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation
Conditions: Cerebral Hemorrhage;   Atrial Fibrillation
Interventions: Drug: Apixaban;   Drug: Aspirin;   Drug: Carbasalate calcium;   Drug: Clopidogrel;   Drug: Dipyridamole;   Other: No antithrombotic treatment
8 Unknown  BLeeding Events and Maintenance DoSe of PraSugrel
Conditions: Adverse Reaction to Antiplatelet Agent;   Acute Coronary Syndrome
Interventions: Drug: Prasugrel dose 5 mg/day;   Drug: Prasugrel dose 10 mg/day
9 Recruiting Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy
Conditions: Coronary Artery Disease;   Myocardial Infarction;   Heart Disease;   Vascular Disease;   Angina Pectoris;   Cardiovascular Disease;   Ischemia;   Infarction;   Embolism;   Thrombosis;   Chest Pain
Interventions: Drug: clopidogrel;   Drug: Ticagrelor or prasugrel
10 Unknown  Platelet Transfusion in Acute Intracerebral Hemorrhage
Condition: Intracerebral Hemorrhage
Intervention: Biological: platelets
11 Unknown  rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets
Condition: Intracerebral Hemorrhage
Interventions: Drug: rFVIIa + (vit K in AO patients);   Drug: FFP or aPCC+ vit K in AO treated patients
12 Recruiting Comparison of Loading Strategies With Antiplatelet Drugs in Patients Undergoing Elective Coronary Intervention
Condition: Angina Pectoris
Interventions: Drug: Prasugrel;   Drug: Clopidogrel
13 Unknown  Standard Clopidogrel Versus Prasugrel Low Dose Therapy in Elderly Patients With Acute Coronary Syndrome
Condition: Coronary Artery Disease
Interventions: Drug: Clopidogrel;   Drug: Prasugrel
14 Unknown  Platelet Function in Patients With an Acute Coronary Syndrome
Condition: Acute Coronary Syndrome (ACS)
Intervention:
15 Recruiting Pharmacodynamic Study of Cilostazol in Healthy Volunteers
Condition: Healthy
Interventions: Drug: Cilostazol;   Drug: Acetylsalicylic acid;   Drug: Clopidogrel
16 Not yet recruiting Effects and Plasma Concentration of Ticagrelor, After Crushed and Non-crushed Intake, After Acute Coronary Syndrome
Condition: Acute Coronary Syndrome
Intervention: Drug: ticagrelor
17 Recruiting What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.
Conditions: Atrial Fibrillations;   Heart Valve Prostheses;   Acute Coronary Syndromes;   Coronary Artery Diseases;   Stroke;   Bleeding;   Myocardial Infarction
Intervention: Drug: Combination of chronic oral anticoagulation and a P2Y12 inhibitor with or without aspirin.
18 Recruiting ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study
Condition: Coronary Artery Disease
Interventions: Drug: 1-month DAPT;   Drug: 12-month DAPT
19 Not yet recruiting Safety of PZ-128 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention
Conditions: Arterial Occlusive Diseases;   Coronary Artery Disease;   Coronary Disease;   Arteriosclerosis;   Heart Diseases;   Myocardial Ischemia;   Vascular Diseases;   Acute Coronary Syndrome
Interventions: Drug: PZ-128;   Drug: Placebo
20 Recruiting Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation
Conditions: Aortic Valve Disease;   Myocardial Infarction;   Stroke;   Bleeding
Interventions: Drug: Aspirin + clopidogrel;   Drug: Aspirin monotherapy;   Drug: OAC + clopicogrel;   Drug: OAC monotherapy

   Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results    Last Page
Indicates status has not been verified in more than two years